全球神經診斷市場

預計到 2030 年全球神經診斷市場規模將達 137 億美元

2024 年全球神經診斷市場規模估計為 93 億美元，預計到 2030 年將達到 137 億美元，2024-2030 年分析期間的複合年成長率為 6.6%。診斷影像系統是報告中分析的細分市場之一，預計到分析期結束時複合年成長率為 6.8%，達到 90 億美元。在分析期內，體外診斷（IVD）部分預計將以 6.0% 的複合年成長率成長。

美國市場預計將達到 24 億美元，中國市場年複合成長率將達到 9.7%

預計 2024 年美國神經診斷市場價值將達 24 億美元。中國是世界第二大經濟體，預計到 2030 年市場規模將達到 32 億美元，2024-2030 年分析期間的複合年成長率為 9.7%。其他值得注意的區域市場包括日本和加拿大，預計在分析期間的複合年成長率分別為 3.6% 和 5.9%。在歐洲，德國的複合年成長率預計為 4.0%。

全球神經診斷市場 - 主要趨勢和促進因素摘要

神經診斷學將如何徹底改變神經系統疾病的檢測？

神經診斷涉及多種技術和測試，用於診斷大腦、神經和脊髓疾病。這些技術包括腦電圖 (EEG)、磁振造影(MRI)、電腦斷層掃描 (CT) 和神經傳導研究。這些診斷工具使醫療保健專業人員能夠識別阿茲海默症、帕金森氏症、中風和多發性硬化症等疾病。隨著神經系統疾病在世界各地變得越來越普遍，對先進的神經診斷工具的需求也顯著成長。向非侵入性診斷技術的轉變進一步推動了神經診斷在臨床和研究環境中的應用。

神經診斷市場的關鍵部分有哪些？

主要類型包括影像學（MRI、 電腦斷層掃描）、電生理學（EEG、EMG）和體外診斷（生物標記、基因測試）。成像方式由於其能夠提供神經系統詳細的結構和功能洞察而獲得了很大的佔有率。神經診斷應用包括疾病診斷、治療監測和研究。主要最終用戶包括依靠神經診斷進行準確診斷和治療計劃的醫院、診斷中心、神經科學診所和研究機構。

神經診斷學如何融入醫療保健系統？

醫院是神經診斷工具的主要用戶，用於緊急和常規神經系統評估。診斷中心在門診病人提供專門的神經診斷服務，而神經科診所則使用這些工具對癲癇和帕金森氏症等疾病進行長期監測。研究機構利用神經診斷學來研究神經系統疾病的病因和發展，為新的治療方法和治癒方法做出貢獻。此外，遠端醫療平台已經開始整合神經診斷技術以進行遠端諮詢，使得診斷服務更容易獲得，特別是在服務不足的地區。

哪些因素推動了神經診斷市場的成長？

神經診斷市場的成長受到多種因素的推動，包括神經系統疾病的盛行率不斷上升，這需要先進的診斷工具進行早期發現和有效管理。影像和電生理學技術的進步提高了診斷的準確性，使得這些工具在臨床實踐中至關重要。個人化醫療和標靶治療的興起也推動了對神經診斷的需求，因為它們為疾病的發病機制提供了關鍵的見解。政府加強醫療保健基礎設施和增加神經學研究資金的措施進一步促進了市場的成長。此外，遠端醫療服務的擴展正在推動對攜帶式和可訪問的神經診斷工具的需求。

部分

產品（診斷影像系統、體外診斷 (IVD)）；疾病（神經退化性疾病、癲癇、中風、頭痛症、睡眠障礙、其他疾病）；最終用戶（診斷實驗室和影像中心、醫院和外科中心、神經學中心、其他最終用戶）

受訪公司範例（總合33家）

• Advanced Brain Monitoring
• ANT Neuro
• Bio-Rad Laboratories
• Canon, Inc.
• DRG Instruments GmbH
• Elmiko Medical Sp. Z oo
• Fonar Corporation
• Fujifilm Holdings Corporation
• Fujirebio
• GE Healthcare
• Hitachi, Ltd.
• Hoffman-La Roche AG
• Lifelines Neuro Company, LLC
• Mitsar Co., Ltd.
• Motion Lab Systems, Inc.
• Natus Medical Incorporated
• Neusoft Medical Systems Co., Ltd.
• Nihon Kohden Corporation
• Philips Healthcare
• Qiagen NV
• Ridge Diagnostics
• Rigaku Corporation
• Siemens Healthineers
• Tecan Trading AG
• Thermo Fisher Scientific, Inc.

目錄

第1章調查方法

第 2 章執行摘要

• 市場概況
• 主要企業
• 市場趨勢和促進因素
• 全球市場展望

第3章 市場分析

• 美國
• 加拿大
• 日本
• 中國
• 歐洲
• 法國
• 德國
• 義大利
• 英國
• 西班牙
• 俄羅斯
• 其他歐洲國家
• 亞太地區
• 澳洲
• 印度
• 韓國
• 其他亞太地區
• 拉丁美洲
• 阿根廷
• 巴西
• 墨西哥
• 其他拉丁美洲國家
• 中東
• 伊朗
• 以色列
• 沙烏地阿拉伯
• 阿拉伯聯合大公國
• 其他中東地區
• 非洲

第4章 競賽

Global Neurodiagnostics Market to Reach US$13.7 Billion by 2030

The global market for Neurodiagnostics estimated at US$9.3 Billion in the year 2024, is expected to reach US$13.7 Billion by 2030, growing at a CAGR of 6.6% over the analysis period 2024-2030. Diagnostic Imaging Systems, one of the segments analyzed in the report, is expected to record a 6.8% CAGR and reach US$9.0 Billion by the end of the analysis period. Growth in the In-vitro diagnostics (IVD) segment is estimated at 6.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.4 Billion While China is Forecast to Grow at 9.7% CAGR

The Neurodiagnostics market in the U.S. is estimated at US$2.4 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$3.2 Billion by the year 2030 trailing a CAGR of 9.7% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.6% and 5.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.0% CAGR.

Global Neurodiagnostics Market - Key Trends and Drivers Summarized

How Is Neurodiagnostics Revolutionizing Neurological Disorder Detection?

Neurodiagnostics encompasses a range of technologies and tests used to diagnose disorders of the brain, nerves, and spinal cord. It includes techniques such as electroencephalography (EEG), magnetic resonance imaging (MRI), computed tomography (CT) scans, and nerve conduction studies, among others. These diagnostic tools enable healthcare professionals to identify conditions such as epilepsy, Alzheimer’s disease, Parkinson’s disease, stroke, and multiple sclerosis. As neurological disorders become more prevalent worldwide, the demand for advanced neurodiagnostic tools has grown significantly. The shift toward non-invasive diagnostic techniques has further propelled the adoption of neurodiagnostics in both clinical and research settings.

What Are The Key Segments in the Neurodiagnostics Market?

Major types include imaging modalities (MRI, CT scans), electrophysiology (EEG, EMG), and in vitro diagnostics (biomarkers, genetic testing). Imaging modalities hold a significant share due to their ability to provide detailed structural and functional insights into the nervous system. Applications of neurodiagnostics include disease diagnosis, treatment monitoring, and research. Key end-users include hospitals, diagnostic centers, neurology clinics, and research institutions, all of which rely on neurodiagnostics for accurate diagnosis and treatment planning.

How Is Neurodiagnostics Being Integrated Across Healthcare Systems?

Hospitals are major users of neurodiagnostic tools, employing them for both emergency and routine neurological assessments. Diagnostic centers offer specialized neurodiagnostic services for outpatient care, while neurology clinics use these tools for long-term monitoring of conditions like epilepsy and Parkinson’s disease. Research institutions utilize neurodiagnostics to study the etiology and progression of neurological disorders, contributing to new treatments and therapies. Additionally, telemedicine platforms are beginning to integrate neurodiagnostics for remote consultations, making diagnostic services more accessible, especially in underserved regions.

What Factors Are Driving the Growth in the Neurodiagnostics Market?

The growth in the neurodiagnostics market is driven by several factors, including the increasing prevalence of neurological disorders, which necessitates advanced diagnostic tools for early detection and effective management. Technological advancements in imaging and electrophysiology have improved diagnostic accuracy, making these tools indispensable in clinical practice. The rise of personalized medicine and targeted therapies has also boosted the demand for neurodiagnostics, as they provide crucial insights into disease pathology. Government initiatives to enhance healthcare infrastructure and increase funding for neurological research are further contributing to market growth. Additionally, the expansion of telehealth services has increased the demand for portable and accessible neurodiagnostic tools.

SCOPE OF STUDY:

The report analyzes the Neurodiagnostics market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Diagnostic Imaging Systems, In-vitro diagnostics (IVD)); Condition (Neuro Degenerative Diseases, Epilepsy, Stroke, Headache Disorders, Sleep Disorders, Other Conditions); End-Use (Diagnostic Laboratories & Imaging Centers, Hospitals & Surgery Centers, Neurology Centers, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 33 Featured) -

• Advanced Brain Monitoring
• ANT Neuro
• Bio-Rad Laboratories
• Canon, Inc.
• DRG Instruments GmbH
• Elmiko Medical Sp. Z o.o.
• Fonar Corporation
• Fujifilm Holdings Corporation
• Fujirebio
• GE Healthcare
• Hitachi, Ltd.
• Hoffman-La Roche AG
• Lifelines Neuro Company, LLC
• Mitsar Co., Ltd.
• Motion Lab Systems, Inc.
• Natus Medical Incorporated
• Neusoft Medical Systems Co., Ltd.
• Nihon Kohden Corporation
• Philips Healthcare
• Qiagen N.V.
• Ridge Diagnostics
• Rigaku Corporation
• Siemens Healthineers
• Tecan Trading AG
• Thermo Fisher Scientific, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Global Economic Update
  • Neurodiagnostics - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Demand for Early Detection of Neurological Disorders Spurs Growth in Neurodiagnostics Market
  • Technological Advancements in Imaging and Molecular Diagnostics Strengthen Business Case for Adoption
  • Increasing Adoption of Neurodiagnostics in Dementia, Stroke, and Epilepsy Diagnosis Expands Market Opportunities
  • Technological Innovations in Functional MRI, PET-CT, and EEG Monitoring Propel Market Expansion
  • Rising Focus on Non-Invasive and Real-Time Diagnostics Drives Demand for Neurodiagnostics
  • Growing Use of Neurodiagnostics in Pediatric and Geriatric Patient Care Expands Market Potential
  • Focus on Meeting FDA and EMA Approval Pathways Strengthens Market for Neurodiagnostics
  • Technological Advancements in AI-Powered Imaging and Brain Mapping Propel Market Growth
  • Increasing Focus on Integrating Neurodiagnostics with Digital Health Platforms and Remote Monitoring Drives Adoption
  • Rising Demand for Neurodiagnostics in Clinical Trials and Drug Development Strengthens Global Market
  • Expansion of Neurodiagnostics in Rehabilitation Centers and Neurocognitive Testing Expands Market Opportunities
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Recent Past, Current & Future Analysis for Neurodiagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 2: World Historic Review for Neurodiagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 3: World 15-Year Perspective for Neurodiagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 4: World Recent Past, Current & Future Analysis for Diagnostic Imaging Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 5: World Historic Review for Diagnostic Imaging Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 6: World 15-Year Perspective for Diagnostic Imaging Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 7: World Recent Past, Current & Future Analysis for Hospitals & Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 8: World Historic Review for Hospitals & Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 9: World 15-Year Perspective for Hospitals & Surgery Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 10: World Recent Past, Current & Future Analysis for Neurology Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 11: World Historic Review for Neurology Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 12: World 15-Year Perspective for Neurology Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 13: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 14: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 15: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 16: World Recent Past, Current & Future Analysis for Neuro Degenerative Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 17: World Historic Review for Neuro Degenerative Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 18: World 15-Year Perspective for Neuro Degenerative Diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 19: World Recent Past, Current & Future Analysis for Epilepsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 20: World Historic Review for Epilepsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 21: World 15-Year Perspective for Epilepsy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 22: World Recent Past, Current & Future Analysis for Stroke by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 23: World Historic Review for Stroke by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 24: World 15-Year Perspective for Stroke by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 25: World Recent Past, Current & Future Analysis for Headache Disorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 26: World Historic Review for Headache Disorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 27: World 15-Year Perspective for Headache Disorders by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 28: World Recent Past, Current & Future Analysis for Sleep Disorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 29: World Historic Review for Sleep Disorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 30: World 15-Year Perspective for Sleep Disorders by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 31: World Recent Past, Current & Future Analysis for Other Conditions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 32: World Historic Review for Other Conditions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 33: World 15-Year Perspective for Other Conditions by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 34: World Neurodiagnostics Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for In-vitro diagnostics (IVD) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for In-vitro diagnostics (IVD) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 37: World 15-Year Perspective for In-vitro diagnostics (IVD) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 38: World Recent Past, Current & Future Analysis for Diagnostic Laboratories & Imaging Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 39: World Historic Review for Diagnostic Laboratories & Imaging Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 40: World 15-Year Perspective for Diagnostic Laboratories & Imaging Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Neurodiagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 41: USA Recent Past, Current & Future Analysis for Neurodiagnostics by Product - Diagnostic Imaging Systems and In-vitro diagnostics (IVD) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 42: USA Historic Review for Neurodiagnostics by Product - Diagnostic Imaging Systems and In-vitro diagnostics (IVD) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 43: USA 15-Year Perspective for Neurodiagnostics by Product - Percentage Breakdown of Value Sales for Diagnostic Imaging Systems and In-vitro diagnostics (IVD) for the Years 2015, 2025 & 2030
  • TABLE 44: USA Recent Past, Current & Future Analysis for Neurodiagnostics by End-Use - Hospitals & Surgery Centers, Neurology Centers, Other End-Uses and Diagnostic Laboratories & Imaging Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 45: USA Historic Review for Neurodiagnostics by End-Use - Hospitals & Surgery Centers, Neurology Centers, Other End-Uses and Diagnostic Laboratories & Imaging Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 46: USA 15-Year Perspective for Neurodiagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Surgery Centers, Neurology Centers, Other End-Uses and Diagnostic Laboratories & Imaging Centers for the Years 2015, 2025 & 2030
  • TABLE 47: USA Recent Past, Current & Future Analysis for Neurodiagnostics by Condition - Neuro Degenerative Diseases, Epilepsy, Stroke, Headache Disorders, Sleep Disorders and Other Conditions - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 48: USA Historic Review for Neurodiagnostics by Condition - Neuro Degenerative Diseases, Epilepsy, Stroke, Headache Disorders, Sleep Disorders and Other Conditions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 49: USA 15-Year Perspective for Neurodiagnostics by Condition - Percentage Breakdown of Value Sales for Neuro Degenerative Diseases, Epilepsy, Stroke, Headache Disorders, Sleep Disorders and Other Conditions for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 50: Canada Recent Past, Current & Future Analysis for Neurodiagnostics by Product - Diagnostic Imaging Systems and In-vitro diagnostics (IVD) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 51: Canada Historic Review for Neurodiagnostics by Product - Diagnostic Imaging Systems and In-vitro diagnostics (IVD) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 52: Canada 15-Year Perspective for Neurodiagnostics by Product - Percentage Breakdown of Value Sales for Diagnostic Imaging Systems and In-vitro diagnostics (IVD) for the Years 2015, 2025 & 2030
  • TABLE 53: Canada Recent Past, Current & Future Analysis for Neurodiagnostics by End-Use - Hospitals & Surgery Centers, Neurology Centers, Other End-Uses and Diagnostic Laboratories & Imaging Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 54: Canada Historic Review for Neurodiagnostics by End-Use - Hospitals & Surgery Centers, Neurology Centers, Other End-Uses and Diagnostic Laboratories & Imaging Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 55: Canada 15-Year Perspective for Neurodiagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Surgery Centers, Neurology Centers, Other End-Uses and Diagnostic Laboratories & Imaging Centers for the Years 2015, 2025 & 2030
  • TABLE 56: Canada Recent Past, Current & Future Analysis for Neurodiagnostics by Condition - Neuro Degenerative Diseases, Epilepsy, Stroke, Headache Disorders, Sleep Disorders and Other Conditions - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Canada Historic Review for Neurodiagnostics by Condition - Neuro Degenerative Diseases, Epilepsy, Stroke, Headache Disorders, Sleep Disorders and Other Conditions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 58: Canada 15-Year Perspective for Neurodiagnostics by Condition - Percentage Breakdown of Value Sales for Neuro Degenerative Diseases, Epilepsy, Stroke, Headache Disorders, Sleep Disorders and Other Conditions for the Years 2015, 2025 & 2030
• JAPAN
  • Neurodiagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 59: Japan Recent Past, Current & Future Analysis for Neurodiagnostics by Product - Diagnostic Imaging Systems and In-vitro diagnostics (IVD) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 60: Japan Historic Review for Neurodiagnostics by Product - Diagnostic Imaging Systems and In-vitro diagnostics (IVD) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 61: Japan 15-Year Perspective for Neurodiagnostics by Product - Percentage Breakdown of Value Sales for Diagnostic Imaging Systems and In-vitro diagnostics (IVD) for the Years 2015, 2025 & 2030
  • TABLE 62: Japan Recent Past, Current & Future Analysis for Neurodiagnostics by End-Use - Hospitals & Surgery Centers, Neurology Centers, Other End-Uses and Diagnostic Laboratories & Imaging Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 63: Japan Historic Review for Neurodiagnostics by End-Use - Hospitals & Surgery Centers, Neurology Centers, Other End-Uses and Diagnostic Laboratories & Imaging Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 64: Japan 15-Year Perspective for Neurodiagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Surgery Centers, Neurology Centers, Other End-Uses and Diagnostic Laboratories & Imaging Centers for the Years 2015, 2025 & 2030
  • TABLE 65: Japan Recent Past, Current & Future Analysis for Neurodiagnostics by Condition - Neuro Degenerative Diseases, Epilepsy, Stroke, Headache Disorders, Sleep Disorders and Other Conditions - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 66: Japan Historic Review for Neurodiagnostics by Condition - Neuro Degenerative Diseases, Epilepsy, Stroke, Headache Disorders, Sleep Disorders and Other Conditions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 67: Japan 15-Year Perspective for Neurodiagnostics by Condition - Percentage Breakdown of Value Sales for Neuro Degenerative Diseases, Epilepsy, Stroke, Headache Disorders, Sleep Disorders and Other Conditions for the Years 2015, 2025 & 2030
• CHINA
  • Neurodiagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 68: China Recent Past, Current & Future Analysis for Neurodiagnostics by Product - Diagnostic Imaging Systems and In-vitro diagnostics (IVD) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 69: China Historic Review for Neurodiagnostics by Product - Diagnostic Imaging Systems and In-vitro diagnostics (IVD) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 70: China 15-Year Perspective for Neurodiagnostics by Product - Percentage Breakdown of Value Sales for Diagnostic Imaging Systems and In-vitro diagnostics (IVD) for the Years 2015, 2025 & 2030
  • TABLE 71: China Recent Past, Current & Future Analysis for Neurodiagnostics by End-Use - Hospitals & Surgery Centers, Neurology Centers, Other End-Uses and Diagnostic Laboratories & Imaging Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 72: China Historic Review for Neurodiagnostics by End-Use - Hospitals & Surgery Centers, Neurology Centers, Other End-Uses and Diagnostic Laboratories & Imaging Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 73: China 15-Year Perspective for Neurodiagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Surgery Centers, Neurology Centers, Other End-Uses and Diagnostic Laboratories & Imaging Centers for the Years 2015, 2025 & 2030
  • TABLE 74: China Recent Past, Current & Future Analysis for Neurodiagnostics by Condition - Neuro Degenerative Diseases, Epilepsy, Stroke, Headache Disorders, Sleep Disorders and Other Conditions - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 75: China Historic Review for Neurodiagnostics by Condition - Neuro Degenerative Diseases, Epilepsy, Stroke, Headache Disorders, Sleep Disorders and Other Conditions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 76: China 15-Year Perspective for Neurodiagnostics by Condition - Percentage Breakdown of Value Sales for Neuro Degenerative Diseases, Epilepsy, Stroke, Headache Disorders, Sleep Disorders and Other Conditions for the Years 2015, 2025 & 2030
• EUROPE
  • Neurodiagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 77: Europe Recent Past, Current & Future Analysis for Neurodiagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 78: Europe Historic Review for Neurodiagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 79: Europe 15-Year Perspective for Neurodiagnostics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 80: Europe Recent Past, Current & Future Analysis for Neurodiagnostics by Product - Diagnostic Imaging Systems and In-vitro diagnostics (IVD) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 81: Europe Historic Review for Neurodiagnostics by Product - Diagnostic Imaging Systems and In-vitro diagnostics (IVD) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 82: Europe 15-Year Perspective for Neurodiagnostics by Product - Percentage Breakdown of Value Sales for Diagnostic Imaging Systems and In-vitro diagnostics (IVD) for the Years 2015, 2025 & 2030
  • TABLE 83: Europe Recent Past, Current & Future Analysis for Neurodiagnostics by End-Use - Hospitals & Surgery Centers, Neurology Centers, Other End-Uses and Diagnostic Laboratories & Imaging Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 84: Europe Historic Review for Neurodiagnostics by End-Use - Hospitals & Surgery Centers, Neurology Centers, Other End-Uses and Diagnostic Laboratories & Imaging Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 85: Europe 15-Year Perspective for Neurodiagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Surgery Centers, Neurology Centers, Other End-Uses and Diagnostic Laboratories & Imaging Centers for the Years 2015, 2025 & 2030
  • TABLE 86: Europe Recent Past, Current & Future Analysis for Neurodiagnostics by Condition - Neuro Degenerative Diseases, Epilepsy, Stroke, Headache Disorders, Sleep Disorders and Other Conditions - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 87: Europe Historic Review for Neurodiagnostics by Condition - Neuro Degenerative Diseases, Epilepsy, Stroke, Headache Disorders, Sleep Disorders and Other Conditions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 88: Europe 15-Year Perspective for Neurodiagnostics by Condition - Percentage Breakdown of Value Sales for Neuro Degenerative Diseases, Epilepsy, Stroke, Headache Disorders, Sleep Disorders and Other Conditions for the Years 2015, 2025 & 2030
• FRANCE
  • Neurodiagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 89: France Recent Past, Current & Future Analysis for Neurodiagnostics by Product - Diagnostic Imaging Systems and In-vitro diagnostics (IVD) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 90: France Historic Review for Neurodiagnostics by Product - Diagnostic Imaging Systems and In-vitro diagnostics (IVD) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 91: France 15-Year Perspective for Neurodiagnostics by Product - Percentage Breakdown of Value Sales for Diagnostic Imaging Systems and In-vitro diagnostics (IVD) for the Years 2015, 2025 & 2030
  • TABLE 92: France Recent Past, Current & Future Analysis for Neurodiagnostics by End-Use - Hospitals & Surgery Centers, Neurology Centers, Other End-Uses and Diagnostic Laboratories & Imaging Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 93: France Historic Review for Neurodiagnostics by End-Use - Hospitals & Surgery Centers, Neurology Centers, Other End-Uses and Diagnostic Laboratories & Imaging Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 94: France 15-Year Perspective for Neurodiagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Surgery Centers, Neurology Centers, Other End-Uses and Diagnostic Laboratories & Imaging Centers for the Years 2015, 2025 & 2030
  • TABLE 95: France Recent Past, Current & Future Analysis for Neurodiagnostics by Condition - Neuro Degenerative Diseases, Epilepsy, Stroke, Headache Disorders, Sleep Disorders and Other Conditions - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 96: France Historic Review for Neurodiagnostics by Condition - Neuro Degenerative Diseases, Epilepsy, Stroke, Headache Disorders, Sleep Disorders and Other Conditions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 97: France 15-Year Perspective for Neurodiagnostics by Condition - Percentage Breakdown of Value Sales for Neuro Degenerative Diseases, Epilepsy, Stroke, Headache Disorders, Sleep Disorders and Other Conditions for the Years 2015, 2025 & 2030
• GERMANY
  • Neurodiagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 98: Germany Recent Past, Current & Future Analysis for Neurodiagnostics by Product - Diagnostic Imaging Systems and In-vitro diagnostics (IVD) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Germany Historic Review for Neurodiagnostics by Product - Diagnostic Imaging Systems and In-vitro diagnostics (IVD) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 100: Germany 15-Year Perspective for Neurodiagnostics by Product - Percentage Breakdown of Value Sales for Diagnostic Imaging Systems and In-vitro diagnostics (IVD) for the Years 2015, 2025 & 2030
  • TABLE 101: Germany Recent Past, Current & Future Analysis for Neurodiagnostics by End-Use - Hospitals & Surgery Centers, Neurology Centers, Other End-Uses and Diagnostic Laboratories & Imaging Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Germany Historic Review for Neurodiagnostics by End-Use - Hospitals & Surgery Centers, Neurology Centers, Other End-Uses and Diagnostic Laboratories & Imaging Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 103: Germany 15-Year Perspective for Neurodiagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Surgery Centers, Neurology Centers, Other End-Uses and Diagnostic Laboratories & Imaging Centers for the Years 2015, 2025 & 2030
  • TABLE 104: Germany Recent Past, Current & Future Analysis for Neurodiagnostics by Condition - Neuro Degenerative Diseases, Epilepsy, Stroke, Headache Disorders, Sleep Disorders and Other Conditions - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Germany Historic Review for Neurodiagnostics by Condition - Neuro Degenerative Diseases, Epilepsy, Stroke, Headache Disorders, Sleep Disorders and Other Conditions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 106: Germany 15-Year Perspective for Neurodiagnostics by Condition - Percentage Breakdown of Value Sales for Neuro Degenerative Diseases, Epilepsy, Stroke, Headache Disorders, Sleep Disorders and Other Conditions for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 107: Italy Recent Past, Current & Future Analysis for Neurodiagnostics by Product - Diagnostic Imaging Systems and In-vitro diagnostics (IVD) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 108: Italy Historic Review for Neurodiagnostics by Product - Diagnostic Imaging Systems and In-vitro diagnostics (IVD) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 109: Italy 15-Year Perspective for Neurodiagnostics by Product - Percentage Breakdown of Value Sales for Diagnostic Imaging Systems and In-vitro diagnostics (IVD) for the Years 2015, 2025 & 2030
  • TABLE 110: Italy Recent Past, Current & Future Analysis for Neurodiagnostics by End-Use - Hospitals & Surgery Centers, Neurology Centers, Other End-Uses and Diagnostic Laboratories & Imaging Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 111: Italy Historic Review for Neurodiagnostics by End-Use - Hospitals & Surgery Centers, Neurology Centers, Other End-Uses and Diagnostic Laboratories & Imaging Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 112: Italy 15-Year Perspective for Neurodiagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Surgery Centers, Neurology Centers, Other End-Uses and Diagnostic Laboratories & Imaging Centers for the Years 2015, 2025 & 2030
  • TABLE 113: Italy Recent Past, Current & Future Analysis for Neurodiagnostics by Condition - Neuro Degenerative Diseases, Epilepsy, Stroke, Headache Disorders, Sleep Disorders and Other Conditions - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 114: Italy Historic Review for Neurodiagnostics by Condition - Neuro Degenerative Diseases, Epilepsy, Stroke, Headache Disorders, Sleep Disorders and Other Conditions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 115: Italy 15-Year Perspective for Neurodiagnostics by Condition - Percentage Breakdown of Value Sales for Neuro Degenerative Diseases, Epilepsy, Stroke, Headache Disorders, Sleep Disorders and Other Conditions for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Neurodiagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 116: UK Recent Past, Current & Future Analysis for Neurodiagnostics by Product - Diagnostic Imaging Systems and In-vitro diagnostics (IVD) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 117: UK Historic Review for Neurodiagnostics by Product - Diagnostic Imaging Systems and In-vitro diagnostics (IVD) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 118: UK 15-Year Perspective for Neurodiagnostics by Product - Percentage Breakdown of Value Sales for Diagnostic Imaging Systems and In-vitro diagnostics (IVD) for the Years 2015, 2025 & 2030
  • TABLE 119: UK Recent Past, Current & Future Analysis for Neurodiagnostics by End-Use - Hospitals & Surgery Centers, Neurology Centers, Other End-Uses and Diagnostic Laboratories & Imaging Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 120: UK Historic Review for Neurodiagnostics by End-Use - Hospitals & Surgery Centers, Neurology Centers, Other End-Uses and Diagnostic Laboratories & Imaging Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 121: UK 15-Year Perspective for Neurodiagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Surgery Centers, Neurology Centers, Other End-Uses and Diagnostic Laboratories & Imaging Centers for the Years 2015, 2025 & 2030
  • TABLE 122: UK Recent Past, Current & Future Analysis for Neurodiagnostics by Condition - Neuro Degenerative Diseases, Epilepsy, Stroke, Headache Disorders, Sleep Disorders and Other Conditions - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 123: UK Historic Review for Neurodiagnostics by Condition - Neuro Degenerative Diseases, Epilepsy, Stroke, Headache Disorders, Sleep Disorders and Other Conditions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 124: UK 15-Year Perspective for Neurodiagnostics by Condition - Percentage Breakdown of Value Sales for Neuro Degenerative Diseases, Epilepsy, Stroke, Headache Disorders, Sleep Disorders and Other Conditions for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 125: Spain Recent Past, Current & Future Analysis for Neurodiagnostics by Product - Diagnostic Imaging Systems and In-vitro diagnostics (IVD) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Spain Historic Review for Neurodiagnostics by Product - Diagnostic Imaging Systems and In-vitro diagnostics (IVD) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 127: Spain 15-Year Perspective for Neurodiagnostics by Product - Percentage Breakdown of Value Sales for Diagnostic Imaging Systems and In-vitro diagnostics (IVD) for the Years 2015, 2025 & 2030
  • TABLE 128: Spain Recent Past, Current & Future Analysis for Neurodiagnostics by End-Use - Hospitals & Surgery Centers, Neurology Centers, Other End-Uses and Diagnostic Laboratories & Imaging Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Spain Historic Review for Neurodiagnostics by End-Use - Hospitals & Surgery Centers, Neurology Centers, Other End-Uses and Diagnostic Laboratories & Imaging Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 130: Spain 15-Year Perspective for Neurodiagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Surgery Centers, Neurology Centers, Other End-Uses and Diagnostic Laboratories & Imaging Centers for the Years 2015, 2025 & 2030
  • TABLE 131: Spain Recent Past, Current & Future Analysis for Neurodiagnostics by Condition - Neuro Degenerative Diseases, Epilepsy, Stroke, Headache Disorders, Sleep Disorders and Other Conditions - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Spain Historic Review for Neurodiagnostics by Condition - Neuro Degenerative Diseases, Epilepsy, Stroke, Headache Disorders, Sleep Disorders and Other Conditions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 133: Spain 15-Year Perspective for Neurodiagnostics by Condition - Percentage Breakdown of Value Sales for Neuro Degenerative Diseases, Epilepsy, Stroke, Headache Disorders, Sleep Disorders and Other Conditions for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 134: Russia Recent Past, Current & Future Analysis for Neurodiagnostics by Product - Diagnostic Imaging Systems and In-vitro diagnostics (IVD) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Russia Historic Review for Neurodiagnostics by Product - Diagnostic Imaging Systems and In-vitro diagnostics (IVD) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 136: Russia 15-Year Perspective for Neurodiagnostics by Product - Percentage Breakdown of Value Sales for Diagnostic Imaging Systems and In-vitro diagnostics (IVD) for the Years 2015, 2025 & 2030
  • TABLE 137: Russia Recent Past, Current & Future Analysis for Neurodiagnostics by End-Use - Hospitals & Surgery Centers, Neurology Centers, Other End-Uses and Diagnostic Laboratories & Imaging Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Russia Historic Review for Neurodiagnostics by End-Use - Hospitals & Surgery Centers, Neurology Centers, Other End-Uses and Diagnostic Laboratories & Imaging Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 139: Russia 15-Year Perspective for Neurodiagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Surgery Centers, Neurology Centers, Other End-Uses and Diagnostic Laboratories & Imaging Centers for the Years 2015, 2025 & 2030
  • TABLE 140: Russia Recent Past, Current & Future Analysis for Neurodiagnostics by Condition - Neuro Degenerative Diseases, Epilepsy, Stroke, Headache Disorders, Sleep Disorders and Other Conditions - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Russia Historic Review for Neurodiagnostics by Condition - Neuro Degenerative Diseases, Epilepsy, Stroke, Headache Disorders, Sleep Disorders and Other Conditions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 142: Russia 15-Year Perspective for Neurodiagnostics by Condition - Percentage Breakdown of Value Sales for Neuro Degenerative Diseases, Epilepsy, Stroke, Headache Disorders, Sleep Disorders and Other Conditions for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Neurodiagnostics by Product - Diagnostic Imaging Systems and In-vitro diagnostics (IVD) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Rest of Europe Historic Review for Neurodiagnostics by Product - Diagnostic Imaging Systems and In-vitro diagnostics (IVD) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 145: Rest of Europe 15-Year Perspective for Neurodiagnostics by Product - Percentage Breakdown of Value Sales for Diagnostic Imaging Systems and In-vitro diagnostics (IVD) for the Years 2015, 2025 & 2030
  • TABLE 146: Rest of Europe Recent Past, Current & Future Analysis for Neurodiagnostics by End-Use - Hospitals & Surgery Centers, Neurology Centers, Other End-Uses and Diagnostic Laboratories & Imaging Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Rest of Europe Historic Review for Neurodiagnostics by End-Use - Hospitals & Surgery Centers, Neurology Centers, Other End-Uses and Diagnostic Laboratories & Imaging Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 148: Rest of Europe 15-Year Perspective for Neurodiagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Surgery Centers, Neurology Centers, Other End-Uses and Diagnostic Laboratories & Imaging Centers for the Years 2015, 2025 & 2030
  • TABLE 149: Rest of Europe Recent Past, Current & Future Analysis for Neurodiagnostics by Condition - Neuro Degenerative Diseases, Epilepsy, Stroke, Headache Disorders, Sleep Disorders and Other Conditions - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Rest of Europe Historic Review for Neurodiagnostics by Condition - Neuro Degenerative Diseases, Epilepsy, Stroke, Headache Disorders, Sleep Disorders and Other Conditions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 151: Rest of Europe 15-Year Perspective for Neurodiagnostics by Condition - Percentage Breakdown of Value Sales for Neuro Degenerative Diseases, Epilepsy, Stroke, Headache Disorders, Sleep Disorders and Other Conditions for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Neurodiagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Neurodiagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 153: Asia-Pacific Historic Review for Neurodiagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 154: Asia-Pacific 15-Year Perspective for Neurodiagnostics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Neurodiagnostics by Product - Diagnostic Imaging Systems and In-vitro diagnostics (IVD) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Asia-Pacific Historic Review for Neurodiagnostics by Product - Diagnostic Imaging Systems and In-vitro diagnostics (IVD) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 157: Asia-Pacific 15-Year Perspective for Neurodiagnostics by Product - Percentage Breakdown of Value Sales for Diagnostic Imaging Systems and In-vitro diagnostics (IVD) for the Years 2015, 2025 & 2030
  • TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for Neurodiagnostics by End-Use - Hospitals & Surgery Centers, Neurology Centers, Other End-Uses and Diagnostic Laboratories & Imaging Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Asia-Pacific Historic Review for Neurodiagnostics by End-Use - Hospitals & Surgery Centers, Neurology Centers, Other End-Uses and Diagnostic Laboratories & Imaging Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 160: Asia-Pacific 15-Year Perspective for Neurodiagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Surgery Centers, Neurology Centers, Other End-Uses and Diagnostic Laboratories & Imaging Centers for the Years 2015, 2025 & 2030
  • TABLE 161: Asia-Pacific Recent Past, Current & Future Analysis for Neurodiagnostics by Condition - Neuro Degenerative Diseases, Epilepsy, Stroke, Headache Disorders, Sleep Disorders and Other Conditions - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Asia-Pacific Historic Review for Neurodiagnostics by Condition - Neuro Degenerative Diseases, Epilepsy, Stroke, Headache Disorders, Sleep Disorders and Other Conditions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 163: Asia-Pacific 15-Year Perspective for Neurodiagnostics by Condition - Percentage Breakdown of Value Sales for Neuro Degenerative Diseases, Epilepsy, Stroke, Headache Disorders, Sleep Disorders and Other Conditions for the Years 2015, 2025 & 2030
• AUSTRALIA
  • Neurodiagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 164: Australia Recent Past, Current & Future Analysis for Neurodiagnostics by Product - Diagnostic Imaging Systems and In-vitro diagnostics (IVD) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Australia Historic Review for Neurodiagnostics by Product - Diagnostic Imaging Systems and In-vitro diagnostics (IVD) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 166: Australia 15-Year Perspective for Neurodiagnostics by Product - Percentage Breakdown of Value Sales for Diagnostic Imaging Systems and In-vitro diagnostics (IVD) for the Years 2015, 2025 & 2030
  • TABLE 167: Australia Recent Past, Current & Future Analysis for Neurodiagnostics by End-Use - Hospitals & Surgery Centers, Neurology Centers, Other End-Uses and Diagnostic Laboratories & Imaging Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 168: Australia Historic Review for Neurodiagnostics by End-Use - Hospitals & Surgery Centers, Neurology Centers, Other End-Uses and Diagnostic Laboratories & Imaging Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 169: Australia 15-Year Perspective for Neurodiagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Surgery Centers, Neurology Centers, Other End-Uses and Diagnostic Laboratories & Imaging Centers for the Years 2015, 2025 & 2030
  • TABLE 170: Australia Recent Past, Current & Future Analysis for Neurodiagnostics by Condition - Neuro Degenerative Diseases, Epilepsy, Stroke, Headache Disorders, Sleep Disorders and Other Conditions - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 171: Australia Historic Review for Neurodiagnostics by Condition - Neuro Degenerative Diseases, Epilepsy, Stroke, Headache Disorders, Sleep Disorders and Other Conditions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 172: Australia 15-Year Perspective for Neurodiagnostics by Condition - Percentage Breakdown of Value Sales for Neuro Degenerative Diseases, Epilepsy, Stroke, Headache Disorders, Sleep Disorders and Other Conditions for the Years 2015, 2025 & 2030
• INDIA
  • Neurodiagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 173: India Recent Past, Current & Future Analysis for Neurodiagnostics by Product - Diagnostic Imaging Systems and In-vitro diagnostics (IVD) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 174: India Historic Review for Neurodiagnostics by Product - Diagnostic Imaging Systems and In-vitro diagnostics (IVD) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 175: India 15-Year Perspective for Neurodiagnostics by Product - Percentage Breakdown of Value Sales for Diagnostic Imaging Systems and In-vitro diagnostics (IVD) for the Years 2015, 2025 & 2030
  • TABLE 176: India Recent Past, Current & Future Analysis for Neurodiagnostics by End-Use - Hospitals & Surgery Centers, Neurology Centers, Other End-Uses and Diagnostic Laboratories & Imaging Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 177: India Historic Review for Neurodiagnostics by End-Use - Hospitals & Surgery Centers, Neurology Centers, Other End-Uses and Diagnostic Laboratories & Imaging Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 178: India 15-Year Perspective for Neurodiagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Surgery Centers, Neurology Centers, Other End-Uses and Diagnostic Laboratories & Imaging Centers for the Years 2015, 2025 & 2030
  • TABLE 179: India Recent Past, Current & Future Analysis for Neurodiagnostics by Condition - Neuro Degenerative Diseases, Epilepsy, Stroke, Headache Disorders, Sleep Disorders and Other Conditions - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 180: India Historic Review for Neurodiagnostics by Condition - Neuro Degenerative Diseases, Epilepsy, Stroke, Headache Disorders, Sleep Disorders and Other Conditions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 181: India 15-Year Perspective for Neurodiagnostics by Condition - Percentage Breakdown of Value Sales for Neuro Degenerative Diseases, Epilepsy, Stroke, Headache Disorders, Sleep Disorders and Other Conditions for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 182: South Korea Recent Past, Current & Future Analysis for Neurodiagnostics by Product - Diagnostic Imaging Systems and In-vitro diagnostics (IVD) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 183: South Korea Historic Review for Neurodiagnostics by Product - Diagnostic Imaging Systems and In-vitro diagnostics (IVD) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 184: South Korea 15-Year Perspective for Neurodiagnostics by Product - Percentage Breakdown of Value Sales for Diagnostic Imaging Systems and In-vitro diagnostics (IVD) for the Years 2015, 2025 & 2030
  • TABLE 185: South Korea Recent Past, Current & Future Analysis for Neurodiagnostics by End-Use - Hospitals & Surgery Centers, Neurology Centers, Other End-Uses and Diagnostic Laboratories & Imaging Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 186: South Korea Historic Review for Neurodiagnostics by End-Use - Hospitals & Surgery Centers, Neurology Centers, Other End-Uses and Diagnostic Laboratories & Imaging Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 187: South Korea 15-Year Perspective for Neurodiagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Surgery Centers, Neurology Centers, Other End-Uses and Diagnostic Laboratories & Imaging Centers for the Years 2015, 2025 & 2030
  • TABLE 188: South Korea Recent Past, Current & Future Analysis for Neurodiagnostics by Condition - Neuro Degenerative Diseases, Epilepsy, Stroke, Headache Disorders, Sleep Disorders and Other Conditions - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 189: South Korea Historic Review for Neurodiagnostics by Condition - Neuro Degenerative Diseases, Epilepsy, Stroke, Headache Disorders, Sleep Disorders and Other Conditions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 190: South Korea 15-Year Perspective for Neurodiagnostics by Condition - Percentage Breakdown of Value Sales for Neuro Degenerative Diseases, Epilepsy, Stroke, Headache Disorders, Sleep Disorders and Other Conditions for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Neurodiagnostics by Product - Diagnostic Imaging Systems and In-vitro diagnostics (IVD) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Rest of Asia-Pacific Historic Review for Neurodiagnostics by Product - Diagnostic Imaging Systems and In-vitro diagnostics (IVD) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 193: Rest of Asia-Pacific 15-Year Perspective for Neurodiagnostics by Product - Percentage Breakdown of Value Sales for Diagnostic Imaging Systems and In-vitro diagnostics (IVD) for the Years 2015, 2025 & 2030
  • TABLE 194: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Neurodiagnostics by End-Use - Hospitals & Surgery Centers, Neurology Centers, Other End-Uses and Diagnostic Laboratories & Imaging Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Rest of Asia-Pacific Historic Review for Neurodiagnostics by End-Use - Hospitals & Surgery Centers, Neurology Centers, Other End-Uses and Diagnostic Laboratories & Imaging Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 196: Rest of Asia-Pacific 15-Year Perspective for Neurodiagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Surgery Centers, Neurology Centers, Other End-Uses and Diagnostic Laboratories & Imaging Centers for the Years 2015, 2025 & 2030
  • TABLE 197: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Neurodiagnostics by Condition - Neuro Degenerative Diseases, Epilepsy, Stroke, Headache Disorders, Sleep Disorders and Other Conditions - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Rest of Asia-Pacific Historic Review for Neurodiagnostics by Condition - Neuro Degenerative Diseases, Epilepsy, Stroke, Headache Disorders, Sleep Disorders and Other Conditions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 199: Rest of Asia-Pacific 15-Year Perspective for Neurodiagnostics by Condition - Percentage Breakdown of Value Sales for Neuro Degenerative Diseases, Epilepsy, Stroke, Headache Disorders, Sleep Disorders and Other Conditions for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • Neurodiagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 200: Latin America Recent Past, Current & Future Analysis for Neurodiagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 201: Latin America Historic Review for Neurodiagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 202: Latin America 15-Year Perspective for Neurodiagnostics by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 203: Latin America Recent Past, Current & Future Analysis for Neurodiagnostics by Product - Diagnostic Imaging Systems and In-vitro diagnostics (IVD) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Latin America Historic Review for Neurodiagnostics by Product - Diagnostic Imaging Systems and In-vitro diagnostics (IVD) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 205: Latin America 15-Year Perspective for Neurodiagnostics by Product - Percentage Breakdown of Value Sales for Diagnostic Imaging Systems and In-vitro diagnostics (IVD) for the Years 2015, 2025 & 2030
  • TABLE 206: Latin America Recent Past, Current & Future Analysis for Neurodiagnostics by End-Use - Hospitals & Surgery Centers, Neurology Centers, Other End-Uses and Diagnostic Laboratories & Imaging Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Latin America Historic Review for Neurodiagnostics by End-Use - Hospitals & Surgery Centers, Neurology Centers, Other End-Uses and Diagnostic Laboratories & Imaging Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 208: Latin America 15-Year Perspective for Neurodiagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Surgery Centers, Neurology Centers, Other End-Uses and Diagnostic Laboratories & Imaging Centers for the Years 2015, 2025 & 2030
  • TABLE 209: Latin America Recent Past, Current & Future Analysis for Neurodiagnostics by Condition - Neuro Degenerative Diseases, Epilepsy, Stroke, Headache Disorders, Sleep Disorders and Other Conditions - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Latin America Historic Review for Neurodiagnostics by Condition - Neuro Degenerative Diseases, Epilepsy, Stroke, Headache Disorders, Sleep Disorders and Other Conditions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 211: Latin America 15-Year Perspective for Neurodiagnostics by Condition - Percentage Breakdown of Value Sales for Neuro Degenerative Diseases, Epilepsy, Stroke, Headache Disorders, Sleep Disorders and Other Conditions for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 212: Argentina Recent Past, Current & Future Analysis for Neurodiagnostics by Product - Diagnostic Imaging Systems and In-vitro diagnostics (IVD) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Argentina Historic Review for Neurodiagnostics by Product - Diagnostic Imaging Systems and In-vitro diagnostics (IVD) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 214: Argentina 15-Year Perspective for Neurodiagnostics by Product - Percentage Breakdown of Value Sales for Diagnostic Imaging Systems and In-vitro diagnostics (IVD) for the Years 2015, 2025 & 2030
  • TABLE 215: Argentina Recent Past, Current & Future Analysis for Neurodiagnostics by End-Use - Hospitals & Surgery Centers, Neurology Centers, Other End-Uses and Diagnostic Laboratories & Imaging Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Argentina Historic Review for Neurodiagnostics by End-Use - Hospitals & Surgery Centers, Neurology Centers, Other End-Uses and Diagnostic Laboratories & Imaging Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 217: Argentina 15-Year Perspective for Neurodiagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Surgery Centers, Neurology Centers, Other End-Uses and Diagnostic Laboratories & Imaging Centers for the Years 2015, 2025 & 2030
  • TABLE 218: Argentina Recent Past, Current & Future Analysis for Neurodiagnostics by Condition - Neuro Degenerative Diseases, Epilepsy, Stroke, Headache Disorders, Sleep Disorders and Other Conditions - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Argentina Historic Review for Neurodiagnostics by Condition - Neuro Degenerative Diseases, Epilepsy, Stroke, Headache Disorders, Sleep Disorders and Other Conditions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 220: Argentina 15-Year Perspective for Neurodiagnostics by Condition - Percentage Breakdown of Value Sales for Neuro Degenerative Diseases, Epilepsy, Stroke, Headache Disorders, Sleep Disorders and Other Conditions for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 221: Brazil Recent Past, Current & Future Analysis for Neurodiagnostics by Product - Diagnostic Imaging Systems and In-vitro diagnostics (IVD) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Brazil Historic Review for Neurodiagnostics by Product - Diagnostic Imaging Systems and In-vitro diagnostics (IVD) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 223: Brazil 15-Year Perspective for Neurodiagnostics by Product - Percentage Breakdown of Value Sales for Diagnostic Imaging Systems and In-vitro diagnostics (IVD) for the Years 2015, 2025 & 2030
  • TABLE 224: Brazil Recent Past, Current & Future Analysis for Neurodiagnostics by End-Use - Hospitals & Surgery Centers, Neurology Centers, Other End-Uses and Diagnostic Laboratories & Imaging Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Brazil Historic Review for Neurodiagnostics by End-Use - Hospitals & Surgery Centers, Neurology Centers, Other End-Uses and Diagnostic Laboratories & Imaging Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 226: Brazil 15-Year Perspective for Neurodiagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Surgery Centers, Neurology Centers, Other End-Uses and Diagnostic Laboratories & Imaging Centers for the Years 2015, 2025 & 2030
  • TABLE 227: Brazil Recent Past, Current & Future Analysis for Neurodiagnostics by Condition - Neuro Degenerative Diseases, Epilepsy, Stroke, Headache Disorders, Sleep Disorders and Other Conditions - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Brazil Historic Review for Neurodiagnostics by Condition - Neuro Degenerative Diseases, Epilepsy, Stroke, Headache Disorders, Sleep Disorders and Other Conditions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 229: Brazil 15-Year Perspective for Neurodiagnostics by Condition - Percentage Breakdown of Value Sales for Neuro Degenerative Diseases, Epilepsy, Stroke, Headache Disorders, Sleep Disorders and Other Conditions for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 230: Mexico Recent Past, Current & Future Analysis for Neurodiagnostics by Product - Diagnostic Imaging Systems and In-vitro diagnostics (IVD) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Mexico Historic Review for Neurodiagnostics by Product - Diagnostic Imaging Systems and In-vitro diagnostics (IVD) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 232: Mexico 15-Year Perspective for Neurodiagnostics by Product - Percentage Breakdown of Value Sales for Diagnostic Imaging Systems and In-vitro diagnostics (IVD) for the Years 2015, 2025 & 2030
  • TABLE 233: Mexico Recent Past, Current & Future Analysis for Neurodiagnostics by End-Use - Hospitals & Surgery Centers, Neurology Centers, Other End-Uses and Diagnostic Laboratories & Imaging Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Mexico Historic Review for Neurodiagnostics by End-Use - Hospitals & Surgery Centers, Neurology Centers, Other End-Uses and Diagnostic Laboratories & Imaging Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 235: Mexico 15-Year Perspective for Neurodiagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Surgery Centers, Neurology Centers, Other End-Uses and Diagnostic Laboratories & Imaging Centers for the Years 2015, 2025 & 2030
  • TABLE 236: Mexico Recent Past, Current & Future Analysis for Neurodiagnostics by Condition - Neuro Degenerative Diseases, Epilepsy, Stroke, Headache Disorders, Sleep Disorders and Other Conditions - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Mexico Historic Review for Neurodiagnostics by Condition - Neuro Degenerative Diseases, Epilepsy, Stroke, Headache Disorders, Sleep Disorders and Other Conditions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 238: Mexico 15-Year Perspective for Neurodiagnostics by Condition - Percentage Breakdown of Value Sales for Neuro Degenerative Diseases, Epilepsy, Stroke, Headache Disorders, Sleep Disorders and Other Conditions for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Neurodiagnostics by Product - Diagnostic Imaging Systems and In-vitro diagnostics (IVD) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Rest of Latin America Historic Review for Neurodiagnostics by Product - Diagnostic Imaging Systems and In-vitro diagnostics (IVD) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 241: Rest of Latin America 15-Year Perspective for Neurodiagnostics by Product - Percentage Breakdown of Value Sales for Diagnostic Imaging Systems and In-vitro diagnostics (IVD) for the Years 2015, 2025 & 2030
  • TABLE 242: Rest of Latin America Recent Past, Current & Future Analysis for Neurodiagnostics by End-Use - Hospitals & Surgery Centers, Neurology Centers, Other End-Uses and Diagnostic Laboratories & Imaging Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Rest of Latin America Historic Review for Neurodiagnostics by End-Use - Hospitals & Surgery Centers, Neurology Centers, Other End-Uses and Diagnostic Laboratories & Imaging Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 244: Rest of Latin America 15-Year Perspective for Neurodiagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Surgery Centers, Neurology Centers, Other End-Uses and Diagnostic Laboratories & Imaging Centers for the Years 2015, 2025 & 2030
  • TABLE 245: Rest of Latin America Recent Past, Current & Future Analysis for Neurodiagnostics by Condition - Neuro Degenerative Diseases, Epilepsy, Stroke, Headache Disorders, Sleep Disorders and Other Conditions - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Rest of Latin America Historic Review for Neurodiagnostics by Condition - Neuro Degenerative Diseases, Epilepsy, Stroke, Headache Disorders, Sleep Disorders and Other Conditions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 247: Rest of Latin America 15-Year Perspective for Neurodiagnostics by Condition - Percentage Breakdown of Value Sales for Neuro Degenerative Diseases, Epilepsy, Stroke, Headache Disorders, Sleep Disorders and Other Conditions for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • Neurodiagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 248: Middle East Recent Past, Current & Future Analysis for Neurodiagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 249: Middle East Historic Review for Neurodiagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 250: Middle East 15-Year Perspective for Neurodiagnostics by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 251: Middle East Recent Past, Current & Future Analysis for Neurodiagnostics by Product - Diagnostic Imaging Systems and In-vitro diagnostics (IVD) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Middle East Historic Review for Neurodiagnostics by Product - Diagnostic Imaging Systems and In-vitro diagnostics (IVD) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 253: Middle East 15-Year Perspective for Neurodiagnostics by Product - Percentage Breakdown of Value Sales for Diagnostic Imaging Systems and In-vitro diagnostics (IVD) for the Years 2015, 2025 & 2030
  • TABLE 254: Middle East Recent Past, Current & Future Analysis for Neurodiagnostics by End-Use - Hospitals & Surgery Centers, Neurology Centers, Other End-Uses and Diagnostic Laboratories & Imaging Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Middle East Historic Review for Neurodiagnostics by End-Use - Hospitals & Surgery Centers, Neurology Centers, Other End-Uses and Diagnostic Laboratories & Imaging Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 256: Middle East 15-Year Perspective for Neurodiagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Surgery Centers, Neurology Centers, Other End-Uses and Diagnostic Laboratories & Imaging Centers for the Years 2015, 2025 & 2030
  • TABLE 257: Middle East Recent Past, Current & Future Analysis for Neurodiagnostics by Condition - Neuro Degenerative Diseases, Epilepsy, Stroke, Headache Disorders, Sleep Disorders and Other Conditions - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Middle East Historic Review for Neurodiagnostics by Condition - Neuro Degenerative Diseases, Epilepsy, Stroke, Headache Disorders, Sleep Disorders and Other Conditions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 259: Middle East 15-Year Perspective for Neurodiagnostics by Condition - Percentage Breakdown of Value Sales for Neuro Degenerative Diseases, Epilepsy, Stroke, Headache Disorders, Sleep Disorders and Other Conditions for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 260: Iran Recent Past, Current & Future Analysis for Neurodiagnostics by Product - Diagnostic Imaging Systems and In-vitro diagnostics (IVD) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Iran Historic Review for Neurodiagnostics by Product - Diagnostic Imaging Systems and In-vitro diagnostics (IVD) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 262: Iran 15-Year Perspective for Neurodiagnostics by Product - Percentage Breakdown of Value Sales for Diagnostic Imaging Systems and In-vitro diagnostics (IVD) for the Years 2015, 2025 & 2030
  • TABLE 263: Iran Recent Past, Current & Future Analysis for Neurodiagnostics by End-Use - Hospitals & Surgery Centers, Neurology Centers, Other End-Uses and Diagnostic Laboratories & Imaging Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Iran Historic Review for Neurodiagnostics by End-Use - Hospitals & Surgery Centers, Neurology Centers, Other End-Uses and Diagnostic Laboratories & Imaging Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 265: Iran 15-Year Perspective for Neurodiagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Surgery Centers, Neurology Centers, Other End-Uses and Diagnostic Laboratories & Imaging Centers for the Years 2015, 2025 & 2030
  • TABLE 266: Iran Recent Past, Current & Future Analysis for Neurodiagnostics by Condition - Neuro Degenerative Diseases, Epilepsy, Stroke, Headache Disorders, Sleep Disorders and Other Conditions - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Iran Historic Review for Neurodiagnostics by Condition - Neuro Degenerative Diseases, Epilepsy, Stroke, Headache Disorders, Sleep Disorders and Other Conditions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 268: Iran 15-Year Perspective for Neurodiagnostics by Condition - Percentage Breakdown of Value Sales for Neuro Degenerative Diseases, Epilepsy, Stroke, Headache Disorders, Sleep Disorders and Other Conditions for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 269: Israel Recent Past, Current & Future Analysis for Neurodiagnostics by Product - Diagnostic Imaging Systems and In-vitro diagnostics (IVD) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Israel Historic Review for Neurodiagnostics by Product - Diagnostic Imaging Systems and In-vitro diagnostics (IVD) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 271: Israel 15-Year Perspective for Neurodiagnostics by Product - Percentage Breakdown of Value Sales for Diagnostic Imaging Systems and In-vitro diagnostics (IVD) for the Years 2015, 2025 & 2030
  • TABLE 272: Israel Recent Past, Current & Future Analysis for Neurodiagnostics by End-Use - Hospitals & Surgery Centers, Neurology Centers, Other End-Uses and Diagnostic Laboratories & Imaging Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Israel Historic Review for Neurodiagnostics by End-Use - Hospitals & Surgery Centers, Neurology Centers, Other End-Uses and Diagnostic Laboratories & Imaging Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 274: Israel 15-Year Perspective for Neurodiagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Surgery Centers, Neurology Centers, Other End-Uses and Diagnostic Laboratories & Imaging Centers for the Years 2015, 2025 & 2030
  • TABLE 275: Israel Recent Past, Current & Future Analysis for Neurodiagnostics by Condition - Neuro Degenerative Diseases, Epilepsy, Stroke, Headache Disorders, Sleep Disorders and Other Conditions - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Israel Historic Review for Neurodiagnostics by Condition - Neuro Degenerative Diseases, Epilepsy, Stroke, Headache Disorders, Sleep Disorders and Other Conditions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 277: Israel 15-Year Perspective for Neurodiagnostics by Condition - Percentage Breakdown of Value Sales for Neuro Degenerative Diseases, Epilepsy, Stroke, Headache Disorders, Sleep Disorders and Other Conditions for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Neurodiagnostics by Product - Diagnostic Imaging Systems and In-vitro diagnostics (IVD) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Saudi Arabia Historic Review for Neurodiagnostics by Product - Diagnostic Imaging Systems and In-vitro diagnostics (IVD) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 280: Saudi Arabia 15-Year Perspective for Neurodiagnostics by Product - Percentage Breakdown of Value Sales for Diagnostic Imaging Systems and In-vitro diagnostics (IVD) for the Years 2015, 2025 & 2030
  • TABLE 281: Saudi Arabia Recent Past, Current & Future Analysis for Neurodiagnostics by End-Use - Hospitals & Surgery Centers, Neurology Centers, Other End-Uses and Diagnostic Laboratories & Imaging Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 282: Saudi Arabia Historic Review for Neurodiagnostics by End-Use - Hospitals & Surgery Centers, Neurology Centers, Other End-Uses and Diagnostic Laboratories & Imaging Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 283: Saudi Arabia 15-Year Perspective for Neurodiagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Surgery Centers, Neurology Centers, Other End-Uses and Diagnostic Laboratories & Imaging Centers for the Years 2015, 2025 & 2030
  • TABLE 284: Saudi Arabia Recent Past, Current & Future Analysis for Neurodiagnostics by Condition - Neuro Degenerative Diseases, Epilepsy, Stroke, Headache Disorders, Sleep Disorders and Other Conditions - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 285: Saudi Arabia Historic Review for Neurodiagnostics by Condition - Neuro Degenerative Diseases, Epilepsy, Stroke, Headache Disorders, Sleep Disorders and Other Conditions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 286: Saudi Arabia 15-Year Perspective for Neurodiagnostics by Condition - Percentage Breakdown of Value Sales for Neuro Degenerative Diseases, Epilepsy, Stroke, Headache Disorders, Sleep Disorders and Other Conditions for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 287: UAE Recent Past, Current & Future Analysis for Neurodiagnostics by Product - Diagnostic Imaging Systems and In-vitro diagnostics (IVD) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 288: UAE Historic Review for Neurodiagnostics by Product - Diagnostic Imaging Systems and In-vitro diagnostics (IVD) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 289: UAE 15-Year Perspective for Neurodiagnostics by Product - Percentage Breakdown of Value Sales for Diagnostic Imaging Systems and In-vitro diagnostics (IVD) for the Years 2015, 2025 & 2030
  • TABLE 290: UAE Recent Past, Current & Future Analysis for Neurodiagnostics by End-Use - Hospitals & Surgery Centers, Neurology Centers, Other End-Uses and Diagnostic Laboratories & Imaging Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 291: UAE Historic Review for Neurodiagnostics by End-Use - Hospitals & Surgery Centers, Neurology Centers, Other End-Uses and Diagnostic Laboratories & Imaging Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 292: UAE 15-Year Perspective for Neurodiagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Surgery Centers, Neurology Centers, Other End-Uses and Diagnostic Laboratories & Imaging Centers for the Years 2015, 2025 & 2030
  • TABLE 293: UAE Recent Past, Current & Future Analysis for Neurodiagnostics by Condition - Neuro Degenerative Diseases, Epilepsy, Stroke, Headache Disorders, Sleep Disorders and Other Conditions - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 294: UAE Historic Review for Neurodiagnostics by Condition - Neuro Degenerative Diseases, Epilepsy, Stroke, Headache Disorders, Sleep Disorders and Other Conditions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 295: UAE 15-Year Perspective for Neurodiagnostics by Condition - Percentage Breakdown of Value Sales for Neuro Degenerative Diseases, Epilepsy, Stroke, Headache Disorders, Sleep Disorders and Other Conditions for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Neurodiagnostics by Product - Diagnostic Imaging Systems and In-vitro diagnostics (IVD) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Rest of Middle East Historic Review for Neurodiagnostics by Product - Diagnostic Imaging Systems and In-vitro diagnostics (IVD) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 298: Rest of Middle East 15-Year Perspective for Neurodiagnostics by Product - Percentage Breakdown of Value Sales for Diagnostic Imaging Systems and In-vitro diagnostics (IVD) for the Years 2015, 2025 & 2030
  • TABLE 299: Rest of Middle East Recent Past, Current & Future Analysis for Neurodiagnostics by End-Use - Hospitals & Surgery Centers, Neurology Centers, Other End-Uses and Diagnostic Laboratories & Imaging Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Rest of Middle East Historic Review for Neurodiagnostics by End-Use - Hospitals & Surgery Centers, Neurology Centers, Other End-Uses and Diagnostic Laboratories & Imaging Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 301: Rest of Middle East 15-Year Perspective for Neurodiagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Surgery Centers, Neurology Centers, Other End-Uses and Diagnostic Laboratories & Imaging Centers for the Years 2015, 2025 & 2030
  • TABLE 302: Rest of Middle East Recent Past, Current & Future Analysis for Neurodiagnostics by Condition - Neuro Degenerative Diseases, Epilepsy, Stroke, Headache Disorders, Sleep Disorders and Other Conditions - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Rest of Middle East Historic Review for Neurodiagnostics by Condition - Neuro Degenerative Diseases, Epilepsy, Stroke, Headache Disorders, Sleep Disorders and Other Conditions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 304: Rest of Middle East 15-Year Perspective for Neurodiagnostics by Condition - Percentage Breakdown of Value Sales for Neuro Degenerative Diseases, Epilepsy, Stroke, Headache Disorders, Sleep Disorders and Other Conditions for the Years 2015, 2025 & 2030
• AFRICA
  • Neurodiagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 305: Africa Recent Past, Current & Future Analysis for Neurodiagnostics by Product - Diagnostic Imaging Systems and In-vitro diagnostics (IVD) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Africa Historic Review for Neurodiagnostics by Product - Diagnostic Imaging Systems and In-vitro diagnostics (IVD) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 307: Africa 15-Year Perspective for Neurodiagnostics by Product - Percentage Breakdown of Value Sales for Diagnostic Imaging Systems and In-vitro diagnostics (IVD) for the Years 2015, 2025 & 2030
  • TABLE 308: Africa Recent Past, Current & Future Analysis for Neurodiagnostics by End-Use - Hospitals & Surgery Centers, Neurology Centers, Other End-Uses and Diagnostic Laboratories & Imaging Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 309: Africa Historic Review for Neurodiagnostics by End-Use - Hospitals & Surgery Centers, Neurology Centers, Other End-Uses and Diagnostic Laboratories & Imaging Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 310: Africa 15-Year Perspective for Neurodiagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals & Surgery Centers, Neurology Centers, Other End-Uses and Diagnostic Laboratories & Imaging Centers for the Years 2015, 2025 & 2030
  • TABLE 311: Africa Recent Past, Current & Future Analysis for Neurodiagnostics by Condition - Neuro Degenerative Diseases, Epilepsy, Stroke, Headache Disorders, Sleep Disorders and Other Conditions - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 312: Africa Historic Review for Neurodiagnostics by Condition - Neuro Degenerative Diseases, Epilepsy, Stroke, Headache Disorders, Sleep Disorders and Other Conditions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 313: Africa 15-Year Perspective for Neurodiagnostics by Condition - Percentage Breakdown of Value Sales for Neuro Degenerative Diseases, Epilepsy, Stroke, Headache Disorders, Sleep Disorders and Other Conditions for the Years 2015, 2025 & 2030

IV. COMPETITION